YTHDF1 and neoplasm: Liu et al. [35] reported that YTHDF1 was upregulated in 17 pairs of GC specimens and paired adjacent non-tumor tissues and developed the m6A gene-based diagnostic signature, which was significantly correlated with the high-risk subtype of GC patients.